| 1 |
35561893 | Metformin Inhibits Multiple Myeloma Serum-induced Endothelial Cell Thrombosis by Down-Regulating miR-532. | 2022 May 10 |
1 |
| 2 |
33007330 | FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling. | 2021 Jan |
1 |
| 3 |
34004440 | Metformin prevents BAFF activation of Erk1/2 from B-cell proliferation and survival by impeding mTOR-PTEN/Akt signaling pathway. | 2021 Jul |
7 |
| 4 |
31789625 | Metformin mediated microRNA-7 upregulation inhibits growth, migration, and invasion of non-small cell lung cancer A549 cells. | 2020 Apr |
2 |
| 5 |
32460900 | Elevated de novo protein synthesis in FMRP-deficient human neurons and its correction by metformin treatment. | 2020 May 27 |
1 |
| 6 |
32872293 | Metformin Derivative HL156A Reverses Multidrug Resistance by Inhibiting HOXC6/ERK1/2 Signaling in Multidrug-Resistant Human Cancer Cells. | 2020 Aug 28 |
1 |
| 7 |
33489797 | Metformin reverses chemoresistance in non-small cell lung cancer via accelerating ubiquitination-mediated degradation of Nrf2. | 2020 Dec |
1 |
| 8 |
30680029 | Metformin protects against sevoflurane-induced neuronal apoptosis through the S1P1 and ERK signaling pathways. | 2019 Feb |
4 |
| 9 |
30911317 | Metformin Promotes Neuronal Differentiation via Crosstalk between Cdk5 and Sox6 in Neuroblastoma Cells. | 2019 |
2 |
| 10 |
29380373 | Metformin attenuates folic-acid induced renal fibrosis in mice. | 2018 Sep |
1 |
| 11 |
29399562 | Antidiabetic Drug Metformin Protects Neuronal Cells against Quinolinic Acid-Induced Excitotoxicity by Decreasing Intracellular Calcium. | 2018 Jan |
5 |
| 12 |
29415987 | Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth. | 2018 Feb 7 |
2 |
| 13 |
29472557 | Metformin exerts multitarget antileukemia activity in JAK2V617F-positive myeloproliferative neoplasms. | 2018 Feb 22 |
1 |
| 14 |
29549478 | Metformin Promotes HaCaT Cell Apoptosis through Generation of Reactive Oxygen Species via Raf-1-ERK1/2-Nrf2 Inactivation. | 2018 Jun |
1 |
| 15 |
29635803 | Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metformin. | 2018 Jul |
1 |
| 16 |
29760016 | Diabetes-Induced Cardiomyocyte Passive Stiffening Is Caused by Impaired Insulin-Dependent Titin Modification and Can Be Modulated by Neuregulin-1. | 2018 Jul 20 |
2 |
| 17 |
30333878 | Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene. | 2018 Nov |
4 |
| 18 |
28927780 | Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells. | 2017 Sep |
2 |
| 19 |
29344202 | Metformin in combination with cisplatin inhibits cell viability and induces apoptosis of human ovarian cancer cells by inactivating ERK 1/2. | 2017 Dec |
2 |
| 20 |
26804175 | Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis. | 2016 Sep 8 |
1 |
| 21 |
26824324 | Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells. | 2016 Apr 19 |
3 |
| 22 |
27391065 | Metformin as a new anti-cancer drug in adrenocortical carcinoma. | 2016 Aug 2 |
1 |
| 23 |
25862373 | Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor. | 2015 May 22 |
1 |
| 24 |
26675396 | [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells]. | 2015 Sep |
1 |
| 25 |
24396411 | Metformin inhibits proliferation of human keratinocytes through a mechanism associated with activation of the MAPK signaling pathway. | 2014 Feb |
2 |
| 26 |
24419232 | Paradoxic effects of metformin on endothelial cells and angiogenesis. | 2014 May |
1 |
| 27 |
24858012 | Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. | 2014 |
2 |
| 28 |
25245054 | Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression. | 2014 Dec |
2 |
| 29 |
25491250 | Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer. | 2014 |
1 |
| 30 |
23362830 | Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells. | 2013 Jul |
1 |
| 31 |
20371705 | Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. | 2010 Jul |
1 |
| 32 |
19414528 | Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1. | 2009 Aug 1 |
2 |
| 33 |
19574398 | Metformin inhibits aromatase via an extracellular signal-regulated kinase-mediated pathway. | 2009 Oct |
1 |
| 34 |
16564524 | Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. | 2006 Apr 24 |
1 |
| 35 |
15983226 | Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin. | 2005 Jul |
1 |